Fellowship · Stony Brook, NY
Sponsored by Stony Brook Medicine
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 183 citations · Lea Baer
Clinical endpoints in oncology - a primer.
American journal of cancer research · 2021 · 277 citations · Achuta Guddati
Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.
Cancer cell · 2021 · 223 citations · Max Greenberg
Malignancy-associated haemophagocytic lymphohistiocytosis.
The Lancet. Haematology · 2022 · 103 citations · Christina Lee
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies.
Cancer discovery · 2022 · 125 citations · Christina Lee
TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.
Nature communications · 2022 · 65 citations · Max Greenberg
ChatGPT in Scientific Writing: A Cautionary Tale.
The American journal of medicine · 2023 · 36 citations · Huichun Zhan
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee.
Cytotherapy · 2024 · 29 citations · Michael Schuster